CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Endo Pharmaceuticals Inc., and Grunenthal GbmH v. Teva Pharmaceuticals USA, Inc., and Barr Laboratories, Inc.

1:12-cv-08060

Overview

Case Number 1:12-cv-08060
Filing Date 2012-11-05
Status Terminated
Termination Date 2016-06-29
Court District Court, S.D. New York (nysd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:145 Civil Action to Obtain Patent
Jury Demand None

Parties

Defendant

Teva Pharmaceutical Industries Ltd. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Endo Pharmaceuticals Inc. Operating Company

Represented By

17 Attorneys Listed

Brian Matthew Goldberg

Dechert, LLP (NJ)

Tel: +1 (609) 955-3200
Fax: +1 (609) 955-3259

902 Carnegie Center, Princeton, NJ 08540

Sharon K. Gagliardi

Dechert LLP

Tel: +1 (215) 994-2278
Fax: +1 (215) 655-2278

Cira Centre, 2929 Arch Street, Philadelphia, PA 19104

Basil James Lewris

Finnegan, Henderson, Farabow, Garrett & Dunner LLP (DC)

Tel: +1 (202) 408-4000
Fax: +1 (202) 408-4400

901 New York Avenue, N.W., Washington, DC 20001

Martin J. Black

Dechert LLP

Tel: +1 (215) 994-2664
Fax: +1 (215) 655-2664

Cira Centre 2929 Arch Street, US, PA 19104

Anthony C. Tridico

Finnegan, Henderson, Farabow, Garrett & Dunner LLP (DC)

Fax: +1 (202) 408-4400

901 New York Avenue, N.W., Washington, DC 20001

Jennifer Howe Roscetti

Finnegan, Henderson, Farabow, Garrett & Dunner LLP (DC)

Tel: +1 (202) 408-4150
Fax: +1 (202) 408-4400

901 New York Avenue, N.W., Washington, DC 20001

Robert D Rhoad

Dechert, LLP

Tel: +1 (609) 955-3269
Fax: +1 (609) 955-3259

502 Carnegie Center, Ste 104

Joann M. Neth

Finnegan, Henderson, Farabow, Garrett & Dunner LLP (DC)

Tel: +1 (202) 408-4028
Fax: +1 (202) 408-4400

901 New York Avenue, N.W., Washington, DC 20001

Stephen D. Hoffman

Wilk Auslander LLP

Tel: +1 (212) 981-2309
Fax: +1 (212) 752-6380

1515 Broadway, 43rd Floor

Thomas Paul Lihan

Dechert LLP

Tel: +1 (609) 955-3205
Fax: +1 (609) 873-9137

902 Carnegie Center - Suite 500, Princeton, NJ 08540

Joshua Isaac Sherman

Dechert, LLP (NYC)

Tel: +1 (212) 698-3802
Fax: +1 (212) 698-3599

1095 Avenue of the Americas, New York, NY 10036-6797

Joseph R. Heffern

Dechert LLP (PA)

Tel: +1 (215) 994-2327
Fax: +1 (215) 655-2327

Cira Centre, 2929 Arch Street

Jonathan D Loeb

Dechert LLP

Tel: +1 (650) 813-4995
Fax: +1 (650) 813-4848

2440 W. El Camino Real, Suite 700, Mountain View, CA 94040

Jeffrey Thomas Fisher

Dechert, LLP (NYC)

Tel: +1 (212) 649-8733
Fax: +1 (212) 698-3599

1095 Avenue of the Americas, New York, NY 10036-6797

Carl Gismervig

Dechert LLP

Tel: +1 (650) 813-4996

2440 W El Camino Real, Sutie 700, Mountain View, CA 94040

Blake Greene

Dechert LLP (TX)

Tel: +1 (512) 394-3041

300 WEst 6th Street, Suite 2010, Austin, TX 78701

Anna M Caviani Pease

DECHERT LLP

Tel: +1 (650) 813-4800

2440 W. El Camino Real, Suite 700, Mountain View, CA 94040

Teva Pharmaceuticals USA, Inc. Operating Company

Represented By

5 Attorneys Listed

Elizabeth J. Holland

Goodwin Procter, LLP (NYC)

Tel: +1 (212) 813-8800
Fax: +1 (212) 355-3333

The New York Times Building, 620 Eighth Avenue

Huiya Wu

Goodwin Procter, LLP (NYC)

Tel: +1 (212) 813-8800
Fax: +1 (212) 355-3333

The New York Times Building, 620 Eighth Avenue

Daniel Peter Margolis

Goodwin Procter, LLP (NYC)

Tel: +1 (212) 813-8800
Fax: +1 (212) 355-3333

The New York Times Building, 620 Eighth Avenue

Brian Jeffrey Robinson

Goodwin Procter, LLP (NYC)

Tel: +1 (212) 813-8800
Fax: +1 (212) 355-3333

The New York Times Building, 620 Eighth Avenue

Christopher Justin Coulson

Kenyon & Kenyon LLP

Tel: +1 (212) 908-6409
Fax: +1 (212) 425-5288

One Broadway, New York, NY 10004

Barr Laboratories, Inc. Operating Company

Represented By

5 Attorneys Listed

Elizabeth J. Holland

Goodwin Procter, LLP (NYC)

Tel: +1 (212) 813-8800
Fax: +1 (212) 355-3333

The New York Times Building, 620 Eighth Avenue

Huiya Wu

Goodwin Procter, LLP (NYC)

Tel: +1 (212) 813-8800
Fax: +1 (212) 355-3333

The New York Times Building, 620 Eighth Avenue

Daniel Peter Margolis

Goodwin Procter, LLP (NYC)

Tel: +1 (212) 813-8800
Fax: +1 (212) 355-3333

The New York Times Building, 620 Eighth Avenue

Brian Jeffrey Robinson

Goodwin Procter, LLP (NYC)

Tel: +1 (212) 813-8800
Fax: +1 (212) 355-3333

The New York Times Building, 620 Eighth Avenue

Christopher Justin Coulson

Kenyon & Kenyon LLP

Tel: +1 (212) 908-6409
Fax: +1 (212) 425-5288

One Broadway, New York, NY 10004

Intervenor

Kashiv Pharma, LLC Operating Company

Represented By

1 Attorneys Listed

Charles Alan Weiss

Holland & Knight LLP (NY)

Tel: +1 (212) 513-3200
Fax: +1 (212) 385-9010

31 West 52nd Street, New York, NY 10019

Counter Defendant

Grunenthal GMBH NPE (Individual / Inventor)

Represented By

12 Attorneys Listed

Matthew James Luneack

Finnegan, Henderson, Farabow, Garrett and Dunner

Tel: +1 (202) 408-4436

Finnegan, Henderson, Farabow, Garrett and Dunner, 901 New York Ave., Nw

Eric Brian LaMons

The Schulman Law Firm LLP

Tel: +1 (646) 688-5486

25 Broadway, Ste 9th Floor

Basil James Lewris

Finnegan, Henderson, Farabow, Garrett & Dunner LLP (DC)

Tel: +1 (202) 408-4000
Fax: +1 (202) 408-4400

901 New York Avenue, N.W., Washington, DC 20001

Sarah Emily Craven

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Tel: +1 (202) 408-4000
Fax: +1 (202) 408-4400

901 New York Ave Nw, Washington, DC 20001

Martin J. Black

Dechert LLP

Tel: +1 (215) 994-2664
Fax: +1 (215) 655-2664

Cira Centre 2929 Arch Street, US, PA 19104

Anthony C. Tridico

Finnegan, Henderson, Farabow, Garrett & Dunner LLP (DC)

Fax: +1 (202) 408-4400

901 New York Avenue, N.W., Washington, DC 20001

Jennifer Howe Roscetti

Finnegan, Henderson, Farabow, Garrett & Dunner LLP (DC)

Tel: +1 (202) 408-4150
Fax: +1 (202) 408-4400

901 New York Avenue, N.W., Washington, DC 20001

Erin Mcgeehan Sommers

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Tel: +1 (202) 408-4292
Fax: +1 (202) 408-4400

901 New York Ave., N.W., Washington, DC 20001

Joann M. Neth

Finnegan, Henderson, Farabow, Garrett & Dunner LLP (DC)

Tel: +1 (202) 408-4028
Fax: +1 (202) 408-4400

901 New York Avenue, N.W., Washington, DC 20001

Stephen D. Hoffman

Wilk Auslander LLP

Tel: +1 (212) 981-2309
Fax: +1 (212) 752-6380

1515 Broadway, 43rd Floor

Marianne Simone Terrot

Finnegan, Henderson, Farabow, Garrett & Dunner LLP (DC)

Tel: +1 (202) 408-4000
Fax: +1 (202) 408-4400

901 New York Avenue, N.W., Washington, DC 20001

Joshua Isaac Sherman

Dechert, LLP (NYC)

Tel: +1 (212) 698-3802
Fax: +1 (212) 698-3599

1095 Avenue of the Americas, New York, NY 10036-6797

Court & Judges

Court

District Court, S.D. New York (nysd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 2 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 9 proceedings
🏛️
USPTO PTAB Trials 4 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (2): GB 🇺🇸 US
Parallel Proceedings Across Jurisdictions (13 found):
PTAB: 4 U.S. Courts: 9
USPTO PTAB Trial 2014-08-22
IPR2014-01365

Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals, Inc.

U.S. Continuation Sibling (8329216)
Status: Final Written Decision
USPTO PTAB Trial 2014-01-16
IPR2014-00361

Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals, Inc.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2014-01-16
IPR2014-00360

Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals, Inc.

U.S. Continuation Sibling (8329216)
Status: Final Written Decision
USPTO PTAB Trial 2013-11-18
IPR2014-00160

Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals Inc.

U.S. Continuation Sibling (7851482)
Status: Terminated-Settled
U.S. District Court 2016-01-19
1:16-cv-00025

Purdue Pharma L.P. v. Abhai, LLC

U.S. Family Sibling (["US7674799", "US7674800", "US7683072", "US8114383", "US8808741", "US8894987", "US8894988", "US8309060", "US9073933", "US9492389", "US9492391", "US9492392", "US9492393", "US9522919", "US8337888", "US9060976"])
Status: DED
U.S. District Court 2015-12-15
1:15-cv-01152

Purdue Pharma L.P. v. Amneal Pharmaceuticals LLC

U.S. Family Sibling (["US7674799", "US7674800", "US7683072", "US8114383", "US8309060", "US8337888", "US8808741", "US8894987", "US8894988", "US9060976", "US9034376", "US9073933"])
Status: DED
U.S. District Court 2013-05-17
1:13-cv-03374

Purdue Pharma L.P. v. PAR Pharmaceutical, Inc.

U.S. Family Sibling (["US8114383"])
Status: NYSD
U.S. District Court 2013-05-17
1:13-cv-03372

Purdue Pharma L.P. v. Amneal Pharmaceuticals, LLC

U.S. Family Sibling (["US8114383", "US8337888"])
Status: NYSD
U.S. District Court 2013-05-15
1:13-cv-03288

Endo Pharmaceuticals Inc. v. Roxane Laboratories, Inc.

Asserted Patent
Status: NYSD
U.S. District Court 2013-05-10
1:13-cv-03188

Purdue Pharma L.P. v. Impax Laboratories, Inc.

U.S. Family Sibling (["US8114383"])
Status: NYSD
U.S. District Court 2012-12-11
1:12-cv-08985

Endo Pharmaceuticals Inc. v. Actavis Inc.

Asserted Patent
Status: NYSD
U.S. District Court 2012-11-14
1:12-cv-08317

Endo Pharmaceuticals Inc. v. Impax Laboratories, Inc.

Asserted Patent
Status: NYSD
U.S. District Court 2012-11-07
1:12-cv-08115

Endo Pharmaceuticals Inc. v. Amneal Pharmaceuticals, LLC

Asserted Patent
Status: NYSD
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

5 Patents

There are 5 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7851482
Method for making analgesics
Filed: 2007-10-03
Issued: 2010-12-14
Active (2.6 yrs remaining) +646d PTA
Expires: 2029-07-10
US8114383
Abuse-proofed dosage form
Filed: 2003-11-20
Issued: 2012-02-14
Expired (Term Ended) +325d PTA
Expires: 2024-10-10
US8309060
Abuse-proofed dosage form
Filed: 2012-01-09
Issued: 2012-11-13
Active (5.1 yrs remaining)
Expires: 2032-01-09
US8309122
Oxymorphone controlled release formulations
Filed: 2007-02-28
Issued: 2012-11-13
Expired (Term Ended)
Expires: 2026-03-08
US8329216
Oxymorphone controlled release formulations
Filed: 2006-06-29
Issued: 2012-12-11
Expired (Term Ended)
Expires: 2025-10-07

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+646 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

24

Dispositive

5

Granted

5

Denied

1

Pending / Review

15

Motions by Category

Procedural / Extension Motion 12 Claim Construction / Markman Filing 1 Motion for Summary Judgment (Rule 56) 1 Motion to Strike / Sanctions 6 Motion for Preliminary Injunction / TRO 3 Motion to Dismiss 1

Key Dispositive Motions & Rulings

Motion to Dismiss Granted
MOTION to Vacate . Document filed by Grunenthal GMBH. (Attachments: # 1 Federal Circuit Opinion, # 2 District Court Post-Trial Opinion, # 3 District Court Judgm...
Entry #290 • 2018-09-18 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
AMENDED JUDGMENT: It is, ORDERED, ADJUDGED AND DECREED: That for the reasons stated in the Court's Findings of Fact and Conclusions of Law dated August 14, 2015...
Entry #265 • 2016-06-29 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
BRIEF by Endo on How The Ebay Factors Favor The Imposition Of Injunctive Relief Under 35 U.S.C. §§ 271(e)(4)(B) And 283. Document filed by Endo Pharmaceuticals ...
Entry #260 • 2016-05-27 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
ORDER: This court's August 14, 2015 decision found that certain of the above-captioned defendants were liable for patent infringement. That decision granted inj...
Entry #256 • 2016-04-29 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
RULE 56.1 STATEMENT. Document filed by Barr Laboratories, Inc., Teva Pharmaceuticals USA, Inc.. (Robinson, Brian) (Entered: 02/18/2015)
Entry #112 • 2015-02-18 Document →
Procedural / Extension Motion Denied
ORDER denying as moot 274 Motion to Intervene; denying as moot 283 Motion for Extension of Time. As such, Kashiv's motions to intervene and for an extension of ...
Entry #287 • 2018-09-04 Document →

Docket Entries

(406 total)
Pleading / Complaint

COMPLAINT against Barr Laboratories, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Filing Fee $ 350.00, Receipt Number 465401052137)Document filed by Endo Pharmaceuticals Inc., Grunenthal GMBH.(sac) (mqu). (Entered: 11/08/2012)

Entry #1 • 2012-11-05
1
Court Order

STANDING ORDER IN RE PILOT PROJECT REGARDING CASE MANAGEMENT TECHNIQUES FOR COMPLEX CIVIL CASES IN THE SOUTHERN DISTRICT OF NEW YORK (See M-10-468 Order filed November 1, 2011). This case is hereby designated for inclusion in the Pilot Project Regarding Case Management Techniques for Complex Civil Cases in the Southern District of New York (the Pilot Project), unless the judge to whom this case is assigned determines otherwise. This case is designated for inclusion in the Pilot Project because it is a class action, an MDL action, or is in one of the following Nature of Suit categories: 160, 245, 315, 355, 365, 385, 410, 830, 840, 850, 893, or 950. The presiding judge in a case that does not otherwise qualify for inclusion in the Pilot Project may nevertheless designate the case for inclusion in the Pilot Project by issuing an order directing that the case be included in the Pilot Project. The description of the Pilot Project, including procedures to be followed, is attached to this Order. (Signed by Judge Loretta A. Preska on 10/31/11) (sac) (Entered: 11/08/2012)

Entry #2 • 2012-11-05
1

CASE REFERRED TO Judge Sidney H. Stein as possibly related to 1:12-cv-3111; 1:12-cv-5083; 1:12-cv-5082; 1:12-cv-5615; 1:12-cv-7582. (sac)

Entry #3 • 2012-11-05
1
No Actions

Mailed notice to Commissioner of Patents and Trademarks to report the filing of this action. (sac)

Entry #4 • 2012-11-05
1
No Actions

SUMMONS ISSUED as to Barr Laboratories, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (sac)

Entry #5 • 2012-11-05
1
No Actions

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc